Concepedia

Yibing Lu

YL

Statistics

Publications

25

Citations

1.2K

H-Index

19

Active since

2010

Affiliations

Second Affiliated Hospital of Nanjing Medical University(Current)

Nanjing Medical University

Yangzhou University

Fudan University

Huaian First People’s Hospital

Yibing Lu is an author at Second Affiliated Hospital of Nanjing Medical University specializing in medicine, diabetes mellitus, and diabetic nephropathy.

ORCID

Publications per year

2010–2024

25

Publications

25

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

, , +17

Tirzepatide for Weight Reduction in Chinese Adults With Obesity

Lin Zhao, Zhifeng Cheng, Yibing Lu et al. · JAMA · 2024 · 109 citations · Full text

, , +5

Resveratrol Attenuates Renal Hypertrophy in Early-Stage Diabetes by Activating AMPK

Dafa Ding, You Na, Xiaomei Wu et al. · American Journal of Nephrology · 2010 · 100 citations

, , +14

Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy

Shanshan Huang, Dafa Ding, Sheng Chen et al. · Scientific Reports · 2017 · 99 citations · Full text

, , +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

, , +17

1–5 of 25